Trial intelligence / Profile preview

Estradiol in COVID-19

NCT04359329Phase 2Terminated

Start
Apr 2020
Primary completion
Jul 2020
Countries
1
01

Overview

A Phase 2 trial of estradiol topical in coronavirus disease 2019 (COVID-19). Started Apr 2020; status: terminated.

02

Drugs

estradiol topical
03

Conditions

coronavirus disease 2019 (COVID-19)

Beyond the preview

Go deeper on NCT04359329.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04359329.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call